Document is current
Any future updates will be listed below
-
Authors
Noren Hooten, Nicole http://orcid.org/0000-0002-1683-3838
Mode, Nicolle A.
Kowalik, Edward
Omoniyi, Victor
Zonderman, Alan B.
Ezike, Ngozi
DiNubile, Mark J.
Levinson, Susan L.
Evans, Michele K. http://orcid.org/0000-0002-8546-2831
-
Funding
Funding for this research was provided by:
National Institute on Aging (AG000513, AG000519)
- License Information
-
More Information
Article History
Received: 9 December 2022
Accepted: 28 February 2023
First Online: 10 March 2023
Declarations
:
: The HANDLS study has been approved by the Institutional Review Board of the National Institutes of Health. Participants provided written informed consent.
: Not applicable.
: EK, SLL and MJD are employed by and own stock in BioAegis Therapeutics, which is developing recombinant human plasma gelsolin for clinical use. Other authors declare that they have no conflicts of interest.
